106 related articles for article (PubMed ID: 2872408)
1. Rapid improvement in sleep apnoea of acromegaly after short-term treatment with somatostatin analogue SMS 201-995.
Chanson P; Timsit J; Benoit O; Augendre B; Moulonguet M; Guillausseau PG; Warnet A; Lubetzki J
Lancet; 1986 May; 1(8492):1270-1. PubMed ID: 2872408
[No Abstract] [Full Text] [Related]
2. [Long-term effects of treatment with SMS 201-995 on sleep apnea syndrome associated with acromegaly].
Esnault S; Merceur C; Kerlan V; Tea SH; le Mevel JC; Bercovici JP; Mabin D
Neurophysiol Clin; 1989 Nov; 19(5):367-72. PubMed ID: 2615748
[TBL] [Abstract][Full Text] [Related]
3. Improvement of sleep apnoea due to acromegaly during short-term treatment with octreotide.
Leibowitz G; Shapiro MS; Salameh M; Glaser B
J Intern Med; 1994 Aug; 236(2):231-5. PubMed ID: 8046324
[TBL] [Abstract][Full Text] [Related]
4. Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity.
Ip MS; Tan KC; Peh WC; Lam KS
Clin Endocrinol (Oxf); 2001 Oct; 55(4):477-83. PubMed ID: 11678830
[TBL] [Abstract][Full Text] [Related]
5. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly.
Herrmann BL; Wessendorf TE; Ajaj W; Kahlke S; Teschler H; Mann K
Eur J Endocrinol; 2004 Sep; 151(3):309-15. PubMed ID: 15362959
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin agonists for treatment of acromegaly.
Ben-Shlomo A; Melmed S
Mol Cell Endocrinol; 2008 May; 286(1-2):192-8. PubMed ID: 18191325
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of ophthalmoplegia in acromegaly with the somatostatin analogue SMS 201-995.
van Liessum PA; Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
Neth J Med; 1988 Jun; 32(5-6):289-92. PubMed ID: 2899298
[No Abstract] [Full Text] [Related]
9. Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.
Ben-Shlomo A; Melmed S
J Clin Endocrinol Metab; 2003 Mar; 88(3):963-8. PubMed ID: 12629068
[No Abstract] [Full Text] [Related]
10. Improvement of diabetes after treatment with somatostatin analogue SMS 201-995 in an acromegalic patient.
Cantalamessa L; Catania A; Baldini M; Orsatti A
Horm Metab Res; 1986 Nov; 18(11):790-1. PubMed ID: 2878866
[TBL] [Abstract][Full Text] [Related]
11. Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly.
Berg C; Wessendorf TE; Mortsch F; Forsting M; Teschler H; Weischer T; Mann K; Saller B; Herrmann BL
Eur J Endocrinol; 2009 Dec; 161(6):829-35. PubMed ID: 19773369
[TBL] [Abstract][Full Text] [Related]
12. The analgesic effect and development of dependency to somatostatin analogue (octreotide) in headache associated with acromegaly.
Popovic V; Paunovic VR; Micic D; Nesovic M; Kendereski A; Djordjevic P; Manojlovic D; Micic J
Horm Metab Res; 1988 Apr; 20(4):250-1. PubMed ID: 2899539
[No Abstract] [Full Text] [Related]
13. Acromegalic arthropathy and sleep apnea.
Barkan A
J Endocrinol; 1997 Oct; 155 Suppl 1():S41-4; discussion S45. PubMed ID: 9389994
[No Abstract] [Full Text] [Related]
14. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
N Engl J Med; 1986 May; 314(21):1390-2. PubMed ID: 2871490
[No Abstract] [Full Text] [Related]
15. Relief of sleep apnea in acromegaly by bromocriptine.
Ziemer DC; Dunlap DB
Am J Med Sci; 1988 Jan; 295(1):49-51. PubMed ID: 3337138
[TBL] [Abstract][Full Text] [Related]
16. Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature.
Buyse B; Michiels E; Bouillon R; Bobbaers H; Demedts M
Eur Respir J; 1997 Jun; 10(6):1401-4. PubMed ID: 9192949
[TBL] [Abstract][Full Text] [Related]
17. Sleep apnoea in acromegaly.
Perks WH; Horrocks PM; Cooper RA; Bradbury S; Allen A; Baldock N; Prowse K; van't Hoff W
Br Med J; 1980 Mar; 280(6218):894-7. PubMed ID: 7388361
[TBL] [Abstract][Full Text] [Related]
18. Experiences with octreotide in acromegaly.
O'Hare JA; Abuaisha F; Cotter T
Ir J Med Sci; 1993 Feb; 162(2):40-2. PubMed ID: 8444580
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of a somatostatin analogue (SMS 201-995) in active acromegaly.
Tolis G; Yotis A; del Pozo E; Pitoulis S
J Neurosurg; 1986 Jul; 65(1):37-40. PubMed ID: 2872284
[TBL] [Abstract][Full Text] [Related]
20. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly.
Plewe G; Beyer J; Krause U; Neufeld M; del Pozo E
Lancet; 1984 Oct; 2(8406):782-4. PubMed ID: 6148524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
